News

GEN - Genetic Engineering and Biotechnology News1d
Vision Loss in Diabetic Mice Promoted by Hypoglycemia, Treated with HIF Inhibitors
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...
Hypoglycemia may contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition: Study
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...
theAsianparent10d
Hypoglycemia in Newborns: Symptoms, Causes, Diagnosis
Tak hanya orang dewasa, hipoglikemia pada bayi baru lahir dapat terjadi. Terlebih jika bayi lahir dari ibu yang tak menjaga ...
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Registrational study in patients with tumor hyperinsulinism (HI) expected to commence mid-year Designation underscores need for therapies to treat severe hypoglycemia in the oncology setting REDWOOD ...
Neuroscience News1d
Low Blood Sugar Triggers Retinal Damage, Vision Loss
New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.
I lost 3.5st in 2 months on Mounjaro, yes I have saggy skin and stretch marks but I’m so much happier being skinny
A MUM who lost a whopping 3.5st in just two months thanks to Mounjaro has revealed she finally feels happy despite having ...
Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results
Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...
Rolling Out2d
Workout timing secrets for type 1 diabetes safety
Learn how properly timed physical activity can help people with type 1 diabetes prevent overnight blood sugar drops while ...
Morningstar3d
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
May 05, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by HI, today ...
News-Medical.Net on MSN1d
Low blood sugar linked to retinal damage in diabetic eye disease
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...
Science Daily1d
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition
Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...